Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Kisspeptin vs Gonadorelin vs hCG vs Enclomiphene

Five compounds, four different entry points into the same axis. The higher up the chain a compound acts, the more of the natural feedback loop stays intact, and the more the pulsatility problem matters. Kisspeptin-10 Activates KISS1R on GnRH neurons Hypothalam

This comparison does not assign a generated winner or score.

  • Five compounds, four different entry points into the same axis. The higher up the chain a compound acts, the more of the natural feedback loop stays intact, and the more the pulsatility problem matters.
  • Kisspeptin-10
  • Activates KISS1R on GnRH neurons
  • Hypothalamus, above GnRH
  • IV bolus and infusion in healthy men; LH 4.1 → 12.4 IU/L at 1 mcg/kg (George 2011)
  • ~4 min half-life; no chronic protocol
  • Kisspeptin-54
  • Same receptor, longer exposure
  • IVF oocyte trigger; LH and testosterone rise in men (Dhillo 2005; Abbara 2015)
  • Tachyphylaxis by day 14 of twice-daily dosing (Jayasena 2009)
  • Gonadorelin
  • Synthetic GnRH, pulsatile LH/FSH release
  • Pituitary
  • Established endocrine use; pulse-pump therapy for hypothalamic hypogonadism
  • Continuous exposure suppresses LH (Conn 1991)
  • hCG
  • Mimics LH directly at the testis
  • Testis (Leydig cells)
  • Long clinical history for fertility and TRT adjunct
  • Bypasses pituitary; no feedback preserved
  • Enclomiphene
  • Blocks estrogen negative feedback
  • Pituitary / hypothalamus
  • Phase II: raised morning testosterone and LH while preserving sperm counts (Wiehle et al., Fertil Steril, 2014, PMID 25044085)
  • Oral SERM, not a peptide; estrogenic side effects
  • Kisspeptin-54 triggering is the most convincing clinical result in the whole file. At 3.2 to 12.8 nmol/kg, oocyte maturation occurred in 95% of women, and no woman developed moderate, severe, or critical ovarian hyperstimulation syndrome (Abbara et al., J Clin Endocrinol Metab, 2015, PMID 26192876). Note what that trial is: one dose, one moment, one supervised outcome. That is where kisspeptin shines and where the evidence stops.
  • For how these fit alongside everything else men reach for, see peptides for men.
More references

Related material

Comparison

Safety comparison

Feature Kisspeptin GnRH agonist hCG Site of action Hypothalamus (top) Pituitary (middle) Gonads (bottom) Half-life Very short (4 min for Kp-10) Short (minutes) Long (days) OHSS ri…

View details →
Comparison

IVF trigger comparison

A prospective analysis of 499 IVF cycles compared all three trigger agents. Peak hormone levels differed significantly. hCG levels peaked at 121 IU/L at 24 hours. LH peaked at app…

View details →